Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course.
about
PD-L1 expression induced by the 2009 pandemic influenza A(H1N1) virus impairs the human T cell responseTwo years after pandemic influenza A/2009/H1N1: what have we learned?Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant WomenInfection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response.Dynamic variations in the peripheral blood lymphocyte subgroups of patients with 2009 pandemic H1N1 swine-origin influenza A virus infectionDuration of viral shedding in hospitalized patients infected with pandemic H1N1Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection.Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenzaCytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adultsCase report: Increased viral receptor expression associated with high viral load and severe pneumonia in a young patient infected with 2009 H1N1 influenza a with no pre-existing conditions.Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responsesCellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.Cytokine and chemokine responses in pediatric patients with severe pneumonia associated with pandemic A/H1N1/2009 influenza virus.Newer influenza antivirals, biotherapeutics and combinations.Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiencyAssessing mathematical models of influenza infections using features of the immune response.The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection.Clinical aspects and cytokine response in adults with seasonal influenza infectionUse it or lose it: establishment and persistence of T cell memory.Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection.HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.The complex link between influenza and severe sepsisImpact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection.IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA.The role of adjuvant immunomodulatory agents for treatment of severe influenza.The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
P2860
Q24339361-AB7BD4F3-3571-4E70-88D8-5C63C380B3F6Q30224656-B3CBEF14-3592-45B9-88BD-BD16FFBC462DQ30360402-3FA004CA-AC30-41B0-B0EC-0092168870B7Q30366119-FE9E42CF-36BD-498F-B0F8-7C92AB155DEFQ30378589-ECC1B749-1CE5-48FD-AE5B-3A0366C60335Q30379268-307F6A46-3D68-457B-B3A8-4BD8271577D2Q30402640-896DF2F2-E1AB-4769-9D17-D815F0334929Q30403064-B2E027AC-D36F-478F-8F4A-5F17CF66AD3BQ30403278-AE01B6FE-5502-4137-950D-BB1C8DFED119Q30406559-EFED44D5-CE93-457C-9E46-FE656699ED03Q30408548-0BE8C9ED-2D68-4B81-A3E6-75A546ED35DAQ30411777-562A1AC9-6B89-4B7E-92E3-A2A84F7D9F06Q30413489-625DD28B-3143-4DEB-A6F8-BE9B45CF149CQ30414543-9DC80772-F728-4AD8-A857-35174BDCF68BQ30418549-4A9D1E05-1B67-469C-B503-755E310A9711Q30456363-6E1D14AB-3CF0-4264-8C8D-DAC7EC0D44A1Q34468857-476FBD91-741A-4B47-86B5-E75E4A92168CQ34611749-F783BDF6-3E0A-4DF4-80ED-0D4F5763B672Q34611788-1719CE63-E200-4391-890F-A7BAFD4D9D18Q34724765-2D35A724-360E-4A82-B896-B8C2118B3DECQ35017312-0FB776E3-404C-4783-AACB-97A91A9579A2Q36449587-695F34C0-9DA8-4C61-B5E1-08755AEDE8C3Q36775011-49B7602C-4FC3-4D70-8991-5452F9665FC8Q37103823-BA8A725B-75F2-4AEA-B8A0-4F26CE3CFD40Q37562976-D3EF6E05-7373-4482-907E-A452E306F14AQ39310460-ED87543C-833E-4036-9FDF-645C03316A4FQ40577440-7DC1946F-0B0B-4C97-88F9-618DF1B05A01Q46139825-77AB9F6F-FC01-4082-A068-B96E42DC4080Q47554935-AC89682D-09E8-4759-9380-75D7EDAA92E4Q57094348-6CB34978-2140-4F93-8803-23FD93622A6D
P2860
Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association of profoundly impa ...... vere or fatal clinical course.
@ast
Association of profoundly impa ...... vere or fatal clinical course.
@en
type
label
Association of profoundly impa ...... vere or fatal clinical course.
@ast
Association of profoundly impa ...... vere or fatal clinical course.
@en
prefLabel
Association of profoundly impa ...... vere or fatal clinical course.
@ast
Association of profoundly impa ...... vere or fatal clinical course.
@en
P2093
P50
P356
P1476
Association of profoundly impa ...... vere or fatal clinical course.
@en
P2093
Concetta Castilletti
Cristiana Gioia
Eleonora Lalle
Federica Ferraro
Federico Martini
Francesco Nicola Lauria
Orlando Armignacco
P304
P356
10.1086/655469
P407
P577
2010-09-01T00:00:00Z